Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

More documents

Recommendations

Info

Cancer: lung First Author and Year of Publication NHMRC Level Study Design Location Dates of Enrolment Characteristics of Study Population † 104 Hyperbaric oxygen therapy Size Age (years) Mean (SD) Sause 1981 119 II RCT USA 1970 to 1977 56 ? ‡ ? Sex Ratio (M:F) * Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard deviation. † Information is given for treatment and control groups, if available. Otherwise, total study population values are stated. ‡ Unstated, unclear, or unknown. Cancer: neuroblastoma First Author and Year of Publication NHMRC Level van der Kleij 1996 120 III-3 Study Design Location Single-arm comparison study The Netherlan ds Dates of Enrolment Characteristics of Study Population † Size Age (years) Mean (SD) ? ‡ 51 6.8 ? Sex Ratio (M:F) * Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard deviation. † Information is given for treatment and control groups, if available. Otherwise, total study population values are stated. ‡ Unstated, unclear, or unknown.
Appendix D Studies excluded in this review Thermal burns 1. Lee HC, Niu KC, Chen SH, Chang LP, Lee AJ. Hyperbaric oxygen therapy in clinical application: a report of 12 year’s experience. Chung Hua I Hsueh Tsa Chih 1989;43:307-16. [Lack of a control group.] Diabetic wounds 1. Lee SS, Chen CY, Chan YS, Yen CY, Chao EK, Ueng SWN. Hyperbaric oxygen in the treatment of diabetic foot infection. Chang Gung Medical journal 1997;20:17-22. [Lack of a non-HBOT group.] 2. Leslie CA, Sapico FL, Ginunas VJ, Adkins RH. Randomised controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care 1988;11:111-15. [Lack of an HBO chamber used.] Non-diabetic wounds 1. Pressure Ulcer Treatment Guideline Panel. Quick reference guide for clinicians: pressure ulcer treatment. Journal of the American Academy of Nurse Practitioners 1995;7:389-406. [Lack of primary data.] Necrotising soft tissue infections 1. Benizri E, Fabiani P, Migliori G, Chevallier D, Peyrottes A, Raucoules M, Amiel J, Mouiel J, Toubol J. Gangrene of the perineum. Urology 1996;47:935-9. [Lack of a non-HBOT group.] 2. Capelli-Schellpfeffer M, Gerber GS. The use of hyperbaric oxygen in urology. Journal of Urology 1999;162:647-54. [Narrative review.] 3. Elliot DC, Kufera JA, Myers RA. Necrotizing soft tissue infections: risk factors for mortality and strategies for management. Annals of Surgery 1996;224:672-83. [Lack of a non-HBOT group.] 4. Gozal D, Ziser A, Shupak A, Ariel A, Melamed Y. Necrotizing fasciitis. Archives of Surgery 1986;121:233-5. [Lack of a non-HBOT group.] 5. Korhonen K, Him M, Niinikoski J. Hyperbaric oxygen in the treatment of Fournier’s gangrene. European Journal of Surgery 1998;164:251-5. [Lack of a non-HBOT group.] 6. Pizzorno R, Bonini F, Donelli A, Stubinski R, Medica M, Carmignani G. Hyperbaric oxygen therapy in the treatment of Fournier;s disease in 11 male patients. Journal of Urology 1997;158:837-40. [Lack of a non-HBOT group.] Hyperbaric oxygen therapy 105
Page 1 and 2:
Hyperbaric Oxygen Therapy November
Page 3 and 4:
Contents Executive summary.........
Page 5 and 6:
Tables Table 1 Measures of disease
Page 7 and 8:
Table 45 Functional neurologic scor
Page 9 and 10:
Figures Figure 1. Outline of search
Page 11 and 12:
Effectiveness Published guidelines
Page 13 and 14:
evidence that exposure to HBO may b
Page 15 and 16:
No available evidence No evidence w
Page 17 and 18:
Introduction The Medicare Services
Page 19 and 20:
Multiplace chambers can accommodate
Page 21 and 22:
Marketing status of the device The
Page 23 and 24:
Table 3 1998 - 1999 self-reported d
Page 25 and 26:
Table 6 retrieval. Indication-speci
Page 27 and 28:
Phase of Search Initial Search Ful
Page 29 and 30:
Conduct of meta-analysis When the d
Page 31 and 32:
early as 1995. The guidelines - kno
Page 33 and 34:
Table 10 Minimum staff qualificatio
Page 35 and 36:
Is it effective? The review assesse
Page 37 and 38:
Table 14 Patient criteria of includ
Page 39 and 40:
offered ample details. The remainin
Page 41 and 42:
characteristics compared to the tre
Page 43 and 44:
Assessment of heterogeneity All the
Page 45 and 46:
Odds ratio 10 1 0.1 0.01 A sensitiv
Page 47 and 48:
Wound healing Two of the five ident
Page 49 and 50:
Studies of necrotising soft tissue
Page 51 and 52:
Summary Table 25 Survival in patien
Page 53 and 54:
Table 29 Therapeutic protocols used
Page 55 and 56:
Osteomyelitis The study by Esterhai
Page 57 and 58:
Summary The HBO group showed a stat
Page 59 and 60:
Summary These results are difficult
Page 61 and 62:
outcomes or that decreased the risk
Page 63 and 64:
Anderson et al 80 recruited non-pre
Page 65 and 66:
Summary The collected evidence exam
Page 67 and 68:
Table 46 Major outcomes following t
Page 69 and 70: Table 50 Therapeutic protocols used
Page 71 and 72: Table 53 Patient criteria of includ
Page 73 and 74: Thirty-seven subjects (comparison g
Page 75 and 76: whose hearing loss was not secondar
Page 77 and 78: tinnitus (6 versus 3 subjects). Non
Page 79 and 80: assume that all participants knew o
Page 83 and 84: Table 65 Descriptive characteristic
Page 87 and 88: These contrasted with the conclusio
Page 89 and 90: Table 73 Patient criteria of includ
Page 91 and 92: Summary There are conflicting resul
Page 93 and 94: Summary separate and previously-stu
Page 95 and 96: need to insulate patients from outs
Page 97 and 98: Reactive effects A reactive effect
Page 99 and 100: Cost of major amputation The hospit
Page 101 and 102: Sensitivity analysis Table 79 shows
Page 103 and 104: Table 80 Estimation of incremental
Page 105 and 106: Sensitivity analysis Table 83 shows
Page 107 and 108: Conclusions Safety Potential risks
Page 109 and 110: Recommendations MSAC recommended th
Page 111 and 112: Appendix B Supporting committee Sup
Page 113 and 114: Appendix C Studies included in this
Page 115 and 116: Necrotising soft tissue infections:
Page 117 and 118: Soft tissue injuries: crush injurie
Page 119: Cancer: cervix First Author and Yea
Page 123 and 124: 2. Shandling AH, Ellestad MH, Hart
Page 125 and 126: 5. Woo TCS, Joseph D, Oxer H. Hyper
Page 127 and 128: 22. Kunkler PB, Boulis-Wassif S, Sh
Page 129 and 130: 45. Wiernik G, Perrins D. The radio
Page 131 and 132: Appendix E Calculation of monoplace
Page 133 and 134: Hence, the total operating costs of
Page 135 and 136: Appendix G Reviews received from ot
Page 137 and 138: Sechrist Industries -- Hyperbaric O
Page 139 and 140: References 1. Hampson N. Hyperbaric
Page 141 and 142: 31. L'Abbe K, Detsky A, O'Rourke K.
Page 143 and 144: 61. Perrins DJ. Influence of hyperb
Page 145 and 146: 89. DiSabato F, Giacovazzo M, Crist
Page 147: 117.Plenk HP. Hyperbaric radiation
show all

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Create successful ePaper yourself

Delete template?

Save as template?